ProShare Advisors’s Caribou Biosciences CRBU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,810
| Closed | -$16.3K | – | 2098 |
|
|
2025
Q1 | $16.3K | Sell |
17,810
-5,360
| -23% | -$4.89K | ﹤0.01% | 2046 |
|
|
2024
Q4 | $36.8K | Buy |
23,170
+2,284
| +11% | +$3.63K | ﹤0.01% | 2217 |
|
|
2024
Q3 | $40.9K | Buy |
20,886
+4,345
| +26% | +$8.52K | ﹤0.01% | 1997 |
|
|
2024
Q2 | $27.1K | Sell |
16,541
-4,366
| -21% | -$7.16K | ﹤0.01% | 1793 |
|
|
2024
Q1 | $107K | Buy |
20,907
+1,704
| +9% | +$8.76K | ﹤0.01% | 1812 |
|
|
2023
Q4 | $110K | Buy |
19,203
+3,728
| +24% | +$21.4K | ﹤0.01% | 1769 |
|
|
2023
Q3 | $74K | Buy |
15,475
+4,107
| +36% | +$19.6K | ﹤0.01% | 1679 |
|
|
2023
Q2 | $48.3K | Buy |
11,368
+538
| +5% | +$2.29K | ﹤0.01% | 1776 |
|
|
2023
Q1 | $57.5K | Sell |
10,830
-1,433
| -12% | -$7.61K | ﹤0.01% | 1658 |
|
|
2022
Q4 | $77K | Buy |
12,263
+963
| +9% | +$6.05K | ﹤0.01% | 1695 |
|
|
2022
Q3 | $119K | Buy |
11,300
+507
| +5% | +$5.34K | ﹤0.01% | 1525 |
|
|
2022
Q2 | $59K | Sell |
10,793
-4,973
| -32% | -$27.2K | ﹤0.01% | 1682 |
|
|
2022
Q1 | $145K | Buy |
15,766
+2,856
| +22% | +$26.3K | ﹤0.01% | 1962 |
|
|
2021
Q4 | $195K | Buy |
+12,910
| New | +$195K | ﹤0.01% | 2043 |
|